Movatterモバイル変換


[0]ホーム

URL:


SG11201604473VA - Apoptosis signal-regulating kinase inhibitors - Google Patents

Apoptosis signal-regulating kinase inhibitors

Info

Publication number
SG11201604473VA
SG11201604473VASG11201604473VASG11201604473VASG11201604473VASG 11201604473V ASG11201604473V ASG 11201604473VASG 11201604473V ASG11201604473V ASG 11201604473VASG 11201604473V ASG11201604473V ASG 11201604473VASG 11201604473V ASG11201604473V ASG 11201604473VA
Authority
SG
Singapore
Prior art keywords
kinase inhibitors
apoptosis signal
regulating kinase
regulating
apoptosis
Prior art date
Application number
SG11201604473VA
Inventor
Gregory Notte
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=52282961&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201604473V(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Sciences IncfiledCriticalGilead Sciences Inc
Publication of SG11201604473VApublicationCriticalpatent/SG11201604473VA/en

Links

Classifications

Landscapes

SG11201604473VA2013-12-202014-12-15Apoptosis signal-regulating kinase inhibitorsSG11201604473VA (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US201361918784P2013-12-202013-12-20
PCT/US2014/070362WO2015095059A1 (en)2013-12-202014-12-15Apoptosis signal-regulating kinase inhibitors

Publications (1)

Publication NumberPublication Date
SG11201604473VAtrue SG11201604473VA (en)2016-07-28

Family

ID=52282961

Family Applications (1)

Application NumberTitlePriority DateFiling Date
SG11201604473VASG11201604473VA (en)2013-12-202014-12-15Apoptosis signal-regulating kinase inhibitors

Country Status (23)

CountryLink
US (2)US9908875B2 (en)
EP (1)EP3083615B1 (en)
JP (3)JP2016540029A (en)
KR (1)KR20160098463A (en)
CN (1)CN105980382A (en)
AP (1)AP2016009248A0 (en)
AU (1)AU2014366235B2 (en)
CA (1)CA2934454C (en)
CL (1)CL2016001538A1 (en)
CR (1)CR20160268A (en)
CU (1)CU20160095A7 (en)
DO (1)DOP2016000136A (en)
EA (1)EA201690973A1 (en)
ES (1)ES2731703T3 (en)
HK (1)HK1226073A1 (en)
IL (1)IL245807A0 (en)
MD (1)MD4658B1 (en)
MX (1)MX2016008254A (en)
NZ (1)NZ720660A (en)
PE (1)PE20160859A1 (en)
PH (1)PH12016501149A1 (en)
SG (1)SG11201604473VA (en)
WO (1)WO2015095059A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
TWI625121B (en)2009-07-132018-06-01基利科學股份有限公司 Inhibitor of kinases that regulate apoptosis signaling
PL2588475T3 (en)*2010-07-022015-10-30Gilead Sciences IncApoptosis signal-regulating kinase inhibitors
UY35212A (en)*2012-12-212014-06-30Gilead Sciences Inc INHIBITORS OF THE KINASE THAT REGULATES THE SIGNAL OF APOPTOSIS
WO2015190613A1 (en)*2014-06-092015-12-17Takeda Pharmaceutical Company LimitedRadiolabeled compounds
CN110036005B (en)*2016-11-162022-09-27广东东阳光药业有限公司Amide derivatives and their use in medicine
WO2018094964A1 (en)*2016-11-252018-05-31武汉大学Method with apoptotic signal-regulated kinase 1n-dimerization serving as target for screening medicament use for treating steatohepatitis
WO2018133139A1 (en)2017-01-212018-07-26宁波知明生物科技有限公司Application of paeoniflorin-6'-o-benzene sulfonate in medicine for treating sjögren's syndrome
PL3572412T3 (en)*2017-01-222021-09-27Fujian Cosunter Pharmaceutical Co., Ltd.Pyridine derivative as ask1 inhibitor and preparation method and use thereof
CN111094250B (en)2017-03-032022-11-04江苏豪森药业集团有限公司Apoptosis signal regulating kinase inhibitor and preparation method and application thereof
AU2018266911C1 (en)2017-05-122022-10-20Enanta Pharmaceuticals, Inc.Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
WO2018218044A2 (en)2017-05-252018-11-29Enanta Pharmaceuticals IncApoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
US10450301B2 (en)2017-05-252019-10-22Enanta Pharmaceuticals, Inc.Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
WO2018218042A1 (en)2017-05-252018-11-29Enanta Pharmaceuticals, Inc.Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
US10597382B2 (en)2017-08-282020-03-24Enanta Pharmaceuticals, Inc.Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
WO2019072130A1 (en)*2017-10-122019-04-18深圳市塔吉瑞生物医药有限公司1, 2, 4-triazole compound
CN111801314B (en)2018-01-022023-10-31西尔洛克治疗公司 ASK1 inhibitor compounds and their uses
CN110407806B (en)*2018-04-282021-08-17深圳微芯生物科技股份有限公司Carboxamide compounds, preparation method and application thereof
US10683289B2 (en)2018-05-022020-06-16Enanta Pharmaceuticals, Inc.Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
JP7328254B2 (en)2018-05-022023-08-16エナンタ ファーマシューティカルズ インコーポレイテッド Tetrazoles containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
TW202035389A (en)*2018-06-272020-10-01美商百健Ma公司Ask1 inhibiting agents
WO2020041417A1 (en)2018-08-222020-02-27Enanta Pharmaceuticals, Inc.Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
WO2020106707A1 (en)2018-11-192020-05-28Enanta Pharmaceuticals, Inc.Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
US11466033B2 (en)2019-03-252022-10-11Enanta Pharmaceuticals, Inc.Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
PL2588475T3 (en)2010-07-022015-10-30Gilead Sciences IncApoptosis signal-regulating kinase inhibitors
UY35212A (en)*2012-12-212014-06-30Gilead Sciences Inc INHIBITORS OF THE KINASE THAT REGULATES THE SIGNAL OF APOPTOSIS

Also Published As

Publication numberPublication date
EA201690973A1 (en)2016-11-30
IL245807A0 (en)2016-08-02
NZ720660A (en)2018-01-26
AU2014366235B2 (en)2017-04-13
KR20160098463A (en)2016-08-18
CA2934454C (en)2019-03-26
CU20160095A7 (en)2016-11-29
US20160318922A1 (en)2016-11-03
JP2019077719A (en)2019-05-23
PE20160859A1 (en)2016-09-18
CL2016001538A1 (en)2016-10-28
PH12016501149A1 (en)2016-08-22
WO2015095059A1 (en)2015-06-25
DOP2016000136A (en)2016-06-30
MD4658B1 (en)2019-11-30
HK1226073A1 (en)2017-09-22
HK1224284A1 (en)2017-08-18
AP2016009248A0 (en)2016-05-31
MX2016008254A (en)2016-10-14
JP6509968B2 (en)2019-05-08
MD20160069A2 (en)2016-11-30
CA2934454A1 (en)2015-06-25
JP2016540029A (en)2016-12-22
CR20160268A (en)2016-08-16
AU2014366235A1 (en)2016-06-16
ES2731703T3 (en)2019-11-18
EP3083615B1 (en)2019-04-17
JP2017193592A (en)2017-10-26
CN105980382A (en)2016-09-28
US9169243B2 (en)2015-10-27
US9908875B2 (en)2018-03-06
US20150175597A1 (en)2015-06-25
EP3083615A1 (en)2016-10-26

Similar Documents

PublicationPublication DateTitle
IL257965A (en)Apoptosis signal-regulating kinase inhibitor
IL245807A0 (en)Apoptosis signal-regulating kinase inhibitors
ZA201603337B (en)Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
SG11201600062RA (en)Pyrimidine derivatives as kinase inhibitors
SG11201508125XA (en)Protein kinase inhibitors
LT2970272T (en)Glycosidase inhibitors
ZA201506156B (en)Novel inhibitors
GB201314578D0 (en)Bicyclic inhibitors
EP2986611A4 (en)Certain protein kinase inhibitors
EP2968358A4 (en)Novel choline kinase inhibitors
ZA201604461B (en)Serine/threonine kinase inhibitors
IL244029A0 (en)Deoxycytidine kinase inhibitors
GB201307155D0 (en)Kinase inhibitors
GB201323021D0 (en)Use of kinase inhibitors
GB201321227D0 (en)Use of kinase inhibitors

[8]ページ先頭

©2009-2025 Movatter.jp